RECRUITING

A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Description

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Study Overview

Study Details

Study overview

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Multicenter Open-Label Feasibility Study of Intraoperative Nerve and Ureter Visualization With Bevonescein in Patients Undergoing Minimally Invasive Abdominopelvic Surgery

A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

Condition
Surgery
Intervention / Treatment

-

Contacts and Locations

San Diego

University of California San Diego, San Diego, California, United States, 92037

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Must be a minimum of 18 years of age
  • * Study participant is planning to proceed with surgery
  • * Willing to provide informed consent
  • * Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after.
  • * Females of childbearing potential must have a negative pregnancy test at screening and during the study.
  • * Patient has had prior surgery at the intended surgical site.
  • * Patient has abnormal cardiac rhythm not controlled by medication.
  • * Patient has moderate to severe renal impairment.
  • * Patient has a history of fluorescein allergy.
  • * Patient has a history of drug-related anaphylactic.
  • * Presence of a concurrent disease or condition that may interfere with study participation.
  • * Presence or history of any condition that, in the view of the investigator, places the patient at high risk of treatment compliance.
  • * Use of any Investigational Product or investigational medial device within 30 days prior to screening.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

Alume Biosciences, Inc.,

Study Record Dates

2025-09